A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

NCT03449251 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Type 2 Diabetes Mellitus

Interventions

DRUG: Apelin
DRUG: Relaxin
DRUG: Normal saline
DIAGNOSTIC_TEST: Verapamil
DIAGNOSTIC_TEST: LN Monomethyl arginine

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]